Session » Plenary Session II
-
Abstract Number: 1784
The Novel Anti-CD40 Monoclonal Antibody CFZ533 Shows Beneficial Effects in Patients with Primary Sjögren’s Syndrome: A Phase IIa Double-Blind, Placebo-Controlled Randomized Trial
-
Abstract Number: 1785
Serious or Opportunistic Infections in Infants Born to Pregnant Women with Rheumatoid Arthritis and Treated with a Biologic Medication
-
Abstract Number: 1786
Lupus Nephritis Is Linked to Immunity to an Intestinal Commensal Lachnospiracaea Species
-
Abstract Number: 1787
Efficacy and Safety of Continuing Versus Withdrawing Adalimumab in Maintaining Remission in Patients with Non-Radiographic Axial Spondyloarthritis